Clinical Trials Directory

Trials / Completed

CompletedNCT02287961

Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With Men

Natural History of Anal Human Papillomavirus Infection and Associated Disease in HIV-infected Men Who Have Sex With Men: Towards an Evidence Base for the Prevention of Anal Cancer.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
516 (actual)
Sponsor
ANRS, Emerging Infectious Diseases · Other Government
Sex
Male
Age
35 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Multicentric epidemiological non-comparative study in France characterising evolution of anal Human papillomavirus (HPV) infection and related lesions and evaluating markers associated with the observed evolution. Estimated enrolment: 500 Principal Outcomes * Detection of high-grade cytological and histological anal lesions by high resolution anoscopy * Spontaneous regression of high-grade anal lesions * Detection of anal HPV infection Intervention (procedure): * Patient medical interview (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits) * Standard proctologic examination with digital rectal examination and 2 anal swabs (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits) * High resolution anoscopy (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits) Only if lesion suggestive of Anal Intraepithelial Neoplasia (AIN) detected during High Resolution Anoscopy (HRA): \- anal biopsy(ies) during HRA Only if high-grade lesion: \- HRA biannually

Detailed description

Intervention (procedure): * Patient medical interview (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits) * Standard proctologic examination with digital rectal examination and 2 anal swabs (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits) * High resolution anoscopy (initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits) Only if lesion suggestive of Anal Intraepithelial Neoplasia (AIN) detected during High Resolution Anoscopy (HRA): \- anal biopsy(ies) during HRA Only if high-grade lesion (Atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H), High grade Superficial Intra-epithelial Lesion (HSIL) or AIN2/3): \- HRA biannually

Conditions

Interventions

TypeNameDescription
PROCEDUREStandard proctologic examination(with digital rectal examination and 2 anal swabs) at initial inclusion visit, M12 and M24 follow-up visits and if applicable M6 and M18 control visits
PROCEDUREHigh resolution anoscopyat initial inclusion visit, Month 12 and Month 24 follow-up visits and if applicable Month 6 and Month 18 control visits
PROCEDUREBiopsy(ies) during High Resolution Anoscopyonly if lesion suggestive of AIN detected during High Resolution Anoscopy
PROCEDUREHigh Resolution Anoscopy biannuallyOnly if high-grade lesion (ASC-H, HSIL ou AIN2/3)

Timeline

Start date
2014-12-02
Primary completion
2022-06-30
Completion
2022-06-30
First posted
2014-11-11
Last updated
2024-08-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02287961. Inclusion in this directory is not an endorsement.